Home
>
National Drug Code (NDC)
>
BEBULIN
BEBULIN - 64193-445-02 - (COAGULATION FACTOR IX HUMAN)
Drug Information of BEBULIN
| Product NDC: | 64193-445 |
| Proprietary Name: | BEBULIN |
| Non Proprietary Name: | COAGULATION FACTOR IX HUMAN |
| Active Ingredient(s): | & nbsp; COAGULATION FACTOR IX HUMAN |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BEBULIN
| Product NDC: | 64193-445 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103112 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19920819 |
Package Information of BEBULIN
| Package NDC: | 64193-445-02 |
| Package Description: | 1 KIT in 1 CARTON (64193-445-02) * 20 mL in 1 VIAL, GLASS (64193-345-01) * 20 mL in 1 VIAL, GLASS (0338-0764-62) |
NDC Information of BEBULIN
| NDC Code | 64193-445-02 |
| Proprietary Name | BEBULIN |
| Package Description | 1 KIT in 1 CARTON (64193-445-02) * 20 mL in 1 VIAL, GLASS (64193-345-01) * 20 mL in 1 VIAL, GLASS (0338-0764-62) |
| Product NDC | 64193-445 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | COAGULATION FACTOR IX HUMAN |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19920819 |
| Marketing Category Name | BLA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
